Literature DB >> 3367706

Androgen receptor concentrations in needle biopsy specimens of human liver.

P Bannister1, C M Meystre, M S Losowsky.   

Abstract

The liver is a steroid-responsive organ and contains high levels of androgen receptors (AR). The present study investigated cytosolic AR concentrations in diseased human liver obtained by needle biopsy. Insufficient tissue was available for full Scatchard analysis. Previous studies have shown the binding affinity of the liver AR to be sufficiently constant to allow the use of a single saturating dose analysis, using 3H-mibolerone as the active ligand, for the estimation of binding sites. Thirteen samples were studied and compared to normal liver. AR was identified in all samples and the level negatively correlated to the degree of liver damage. A role for AR in hepatocellular carcinoma has been postulated and anti-androgens used in treatment. This study shows AR can be measured in needle-biopsy specimens and, if hepatocellular carcinoma is proven to be hormone sensitive, then this technique may help in the assessment of such tumours.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367706     DOI: 10.1111/j.1600-0676.1988.tb00963.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.

Authors:  P K Eagon; A Francavilla; A DiLeo; M S Elm; L Gennari; V Mazzaferro; G Colella; D H Van Thiel; T E Strazl
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 2.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

Review 3.  The androgen receptor as an emerging target in hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Osamu Yokosuka
Journal:  J Hepatocell Carcinoma       Date:  2015-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.